| Vol. 11.25 – 29 June, 2022 |
| |
|
|
| Scientists collected induced sputum samples from a cohort of non-smokers, smokers, 3rd generation e-cigarette users, and 4th generation e-cigarette users and evaluated the cellular and fluid phase composition for markers of inflammation, host defense, and lung injury. [American Journal of Respiratory and Critical Care Medicine] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers compared the genomic effects of formoterol, a β2-adrenoceptor agonist, with forskolin in human primary bronchial epithelial cells. [British Journal of Pharmacology] |
|
|
|
| Investigators developed a novel and flexible mouse model of acute epithelial lung injury based on adeno-associated virus (AAV) variant 6.2 mediated expression of the human diphtheria toxin receptor (DTR). [American Journal of Physiology-Lung Cellular and Molecular Physiology] |
|
|
|
| Scientists determined whether hypoxia-inducible factors (HIF) stabilization in SM22α expressing cells mitigated hyperoxia-induced neonatal lung injury. [American Journal of Physiology-Lung Cellular and Molecular Physiology] |
|
|
|
| The authors established a mouse model to explore the effect of radiation on Aspergillus fumigatus infection and the associated mechanisms. [Cell Communication and Signaling] |
|
|
|
| Researchers investigated the role of developmental endothelial locus-1 (DEL-1) in lipopolysaccharide-induced acute lung injury in mouse models and its ability to regulate on eosinophil recruitment. [International Immunopharmacology] |
|
|
|
| Scientists developed two novel pH-only and pH- and thermo-responsive theranostic nanoparticle formulations to deliver an anticancer drug and track the accumulation and therapeutic efficacy of the formulations through inherent fluorescence. [Pharmaceutical Research] |
| |
|
|
| Investigators designed an miR-19a/b sponge plasmid and transfected it into A549 lung cancer cell lines and analyzed its effects on PTEN and TP53INP1 gene expression as the main miR-19a/b target and apoptosis rate in these cell lines. [Molecular Biology Reports] |
|
|
|
| Researchers investigated the role of miR-181a-5p in lung cancer. Expression patterns of miR-181a-5p and G2 and S phase-expressed-1 in the human NSCLC cell line A549 and normal lung epithelial cell line BASE-2B were detected. [Cells Tissues Organs] |
|
|
|
|
| The authors reviewed and discussed the status of active research areas involving stem cells, cellular therapeutics, and bioengineering as they relate to the human lung. [American Journal of Physiology-Lung Cellular and Molecular Physiology] |
|
|
|
|
| AN2 Therapeutics, Inc. announced it has screened its first patient in its pivotal Phase II/III clinical trial evaluating once-daily, oral epetraborole for treatment-refractory Mycobacterium avium complex (MAC) lung disease, the most common form of nontuberculous mycobacterial lung disease. [AN2 Therapeutics, Inc.] |
|
|
|
| A team of New York City lung cancer experts, led by investigators at NYU Langone Health’s Perlmutter Cancer Center, have received a three-year, $1 million grant from Stand Up To Cancer® to bring technology-enabled immunotherapy monitoring to under-represented patient populations. [NYU Langone Health] |
|
|
|
|
| December 10 – 14, 2022 Maui, Hawai’i, United States |
|
|
|
|
| University of Maryland School of Medicine – Baltimore, Maryland, United States |
|
|
|
| McGill University – Montreal, Quebec, Canada |
|
|
|
| Pennsylvania State University – State College, Pennsylvania, United States |
|
|
|
| Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
| Washington University School of Medicine – St. Louis, Missouri, United States |
|
|
|
|